CorMedix, Inc. (CRMD)
7.85
-0.25
(-3.09%)
USD |
NASDAQ |
Oct 23, 16:00
7.86
+0.01
(+0.13%)
After-Hours: 20:00
CorMedix Price : 7.85 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 8.01 | 8.11 | 7.79 | 7.85 | 894539.0 |
| Oct 22, 2026 | 7.86 | 8.12 | 7.76 | 8.10 | 1.092M |
| Oct 21, 2026 | 7.55 | 7.845 | 7.514 | 7.79 | 1.050M |
| Oct 20, 2026 | 7.38 | 7.61 | 7.38 | 7.57 | 971709.0 |
| Oct 19, 2026 | 7.26 | 7.57 | 7.25 | 7.38 | 1.472M |
| Oct 16, 2026 | 7.47 | 7.47 | 7.235 | 7.26 | 1.141M |
| Oct 15, 2026 | 7.49 | 7.695 | 7.43 | 7.46 | 1.466M |
| Oct 14, 2026 | 7.36 | 7.53 | 7.27 | 7.39 | 1.125M |
| Oct 13, 2026 | 7.43 | 7.545 | 7.33 | 7.39 | 1.416M |
| Oct 12, 2026 | 7.41 | 7.60 | 7.157 | 7.46 | 1.592M |
| Oct 09, 2026 | 7.32 | 7.455 | 7.26 | 7.38 | 1.195M |
| Oct 08, 2026 | 7.28 | 7.36 | 7.18 | 7.32 | 1.018M |
| Oct 07, 2026 | 7.27 | 7.31 | 7.18 | 7.28 | 833077.0 |
| Oct 06, 2026 | 7.38 | 7.40 | 7.125 | 7.28 | 744256.0 |
| Oct 05, 2026 | 7.18 | 7.33 | 7.055 | 7.26 | 1.257M |
| Oct 02, 2026 | 7.45 | 7.45 | 7.165 | 7.19 | 1.125M |
| Oct 01, 2026 | 7.65 | 7.685 | 7.40 | 7.42 | 1.053M |
| Sep 30, 2026 | 7.95 | 7.95 | 7.66 | 7.70 | 948364.0 |
| Sep 29, 2026 | 7.91 | 7.96 | 7.82 | 7.93 | 817427.0 |
| Sep 28, 2026 | 7.772 | 7.90 | 7.772 | 7.89 | 485279.0 |
| Sep 25, 2026 | 7.79 | 7.90 | 7.69 | 7.85 | 606653.0 |
| Sep 24, 2026 | 7.70 | 7.785 | 7.62 | 7.77 | 946581.0 |
| Sep 23, 2026 | 8.025 | 8.185 | 7.625 | 7.69 | 812571.0 |
| Sep 22, 2026 | 7.83 | 7.83 | 7.69 | 7.78 | 788927.0 |
| Sep 21, 2026 | 7.72 | 7.82 | 7.62 | 7.77 | 505842.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Filana Therapeutics, Inc. | 0.6355 |
| Eloxx Pharmaceuticals, Inc. | 12.80 |
| Breakthrough Chemistry, Inc. | 0.095 |
| BioStem Technologies, Inc. | 1.57 |
| Cardiac Biotech Solutions, Inc. | 0.0327 |
Price Related Metrics
| PE Ratio | 3.730 |
| PS Ratio | 1.552 |
| PEG Ratio | 0.0205 |
| Price to Book Value | 1.323 |
| Price to Free Cash Flow | 2.869 |
| Earnings Yield | 26.81% |
| Market Cap | 609.69M |
| PEGY Ratio | 0.0205 |
| Operating PE Ratio | 3.306 |
| Normalized PE Ratio | 3.565 |